BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 24423237)

  • 41. Community pharmacy services in the United Arab Emirates.
    Hasan S; Sulieman H; Chapman CB; Stewart K; Kong DC
    Int J Pharm Pract; 2012 Aug; 20(4):218-25. PubMed ID: 22775518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An exploratory study of the views of community pharmacy staff on the management of patients with undiagnosed skin problems.
    Tucker R; Stewart D
    Int J Pharm Pract; 2015 Dec; 23(6):390-8. PubMed ID: 25689029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Community pharmacists' perspectives on implementation of Medicines Use Review in Slovenia.
    Nabergoj Makovec U; Kos M; Pisk N
    Int J Clin Pharm; 2018 Oct; 40(5):1180-1188. PubMed ID: 29909563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacists' perspectives about their role in care of patients with diabetes observing Ramadan.
    Almansour HA; Chaar B; Saini B
    Res Social Adm Pharm; 2017; 13(1):109-122. PubMed ID: 27053428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A national study into the rural and remote pharmacist workforce.
    Smith JD; White C; Roufeil L; Veitch C; Pont L; Patel B; Battye K; Luetsch K; Mitchell C
    Rural Remote Health; 2013; 13(2):2214. PubMed ID: 23683357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Community pharmacists' perceptions, attitudes and barriers towards pharmacist-led minor ailment services in Malaysia.
    Selvaraj A; Redzuan AM; Hatah E
    Int J Clin Pharm; 2020 Apr; 42(2):777-785. PubMed ID: 32006142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Funding for change: New Zealand pharmacists' views on, and experiences of, the community pharmacy services agreement.
    Kinsey H; Scahill S; Bye L; Harrison J
    Int J Pharm Pract; 2016 Dec; 24(6):379-389. PubMed ID: 27121985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Competence, competition and collaboration: Perceived challenges among Swedish community pharmacists engaging in pharmaceutical services provision and research.
    Frisk P; Holtendal C; Bastholm-Rahmner P; Sporrong SK
    Int J Pharm Pract; 2019 Aug; 27(4):346-354. PubMed ID: 30707481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of community pharmacists in providing clinical medication reviews.
    Laaksonen R; Duggan C; Bates I
    Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacists' perspectives on HIV testing in community pharmacies.
    Ryder PT; Meyerson BE; Coy KC; von Hippel CD
    J Am Pharm Assoc (2003); 2013; 53(6):595-600. PubMed ID: 24091415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cluster randomised controlled trial evaluating the clinical and humanistic impact of a pharmacist-led minor ailment service.
    Dineen-Griffin S; Benrimoj SI; Rogers K; Williams KA; Garcia-Cardenas V
    BMJ Qual Saf; 2020 Nov; 29(11):921-931. PubMed ID: 32139400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a training and communication-network nephrology program for community pharmacists.
    Lalonde L; Normandeau M; Lamarre D; Lord A; Berbiche D; Corneille L; Prud'homme L; Laliberté MC
    Pharm World Sci; 2008 Dec; 30(6):924-33. PubMed ID: 18802782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rural health systems' perceptions of referral to community pharmacists during transitions of care.
    Paul S; DiDonato KL; Liu Y; Hartwig DM; May J; Schramm AM
    J Am Pharm Assoc (2003); 2016; 56(5):562-567.e2. PubMed ID: 27475835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Practical strategies and perceptions from community pharmacists following their experiences with conducting pharmacy practice research: a qualitative content analysis.
    De Vera MA; Campbell NKJ; Chhina H; Galo JS; Marra C
    Int J Pharm Pract; 2018 Aug; 26(4):302-309. PubMed ID: 29071805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacists' and pharmacy technicians' views on a process of revalidation of pharmacy professionals in Great Britain.
    Potter H; Hassell K; Noyce PR
    Res Social Adm Pharm; 2013; 9(2):142-54. PubMed ID: 23517656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany.
    Berger K; Eickhoff C; Schulz M
    J Clin Pharm Ther; 2005 Feb; 30(1):45-57. PubMed ID: 15659003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simulated patient visits with immediate feedback to improve the supply of over-the-counter medicines: a feasibility study.
    Watson MC; Cleland JA; Bond CM
    Fam Pract; 2009 Dec; 26(6):532-42. PubMed ID: 19828574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anticoagulation management services in community pharmacy: Feasibility of implementing a quality improvement programme through a practice-based research network.
    Chartrand M; Lalonde L; Cantin A; Lahaie A; Odobasic B; Tremblay MP; Wazzan D; Gagnon MM; Martin É; Dorais M; Berbiche D; Guénette L
    J Clin Pharm Ther; 2018 Dec; 43(6):877-887. PubMed ID: 30019341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.